GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit
Launched by JØRGEN BJERGGAARD JENSEN · Feb 26, 2024
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Methods:
Citizens of Greenland above the age of 18 years referred for cystoscopy will be invited to participate in an observational study at the time of already planned cystoscopy.
Hypothesis:
The investigators hypothesize that the Xpert® Bladder Cancer Detection test can identify patients with a bladder tumor and serve as a future selection tool to support clinical decision whether to perform a cystoscopy or not - especially in areas with limited access to urological services.
Perspectives:
The investigators hope to improve the current poor prognosis for bladder cancer patients in Gre...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years of age at the time of signing the Informed Consent Form with an indication for cystoscopy and planned for this already at study inclusion.
- • Ability to understand the Participant Information Sheet orally and in writing in either Danish or Greenlandic.
- • Signed Informed Consent Form.
- • Is, according to the Investigator's judgement, able to comply with the trial protocol.
- Exclusion Criteria:
- • Patients not willing to participate.
About Jørgen Bjerggaard Jensen
Jørgen Bjerggaard Jensen is a distinguished clinical trial sponsor known for his commitment to advancing medical research and enhancing patient care. With extensive experience in clinical development, he oversees a diverse portfolio of trials aimed at evaluating innovative therapies and improving treatment outcomes across various therapeutic areas. His leadership is characterized by a focus on rigorous scientific methodology, adherence to regulatory standards, and the ethical conduct of research. Jørgen's collaborative approach fosters strong partnerships with research institutions and healthcare professionals, ensuring the successful execution of clinical trials that contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, , Denmark
Nuuk, , Greenland
Patients applied
Trial Officials
Nathalie D Fryd, MD
Principal Investigator
PhD student
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported